Literature DB >> 18726086

Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus.

D R McCance, P Damm, E R Mathiesen, M Hod, R Kaaja, F Dunne, L E Jensen, H Mersebach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18726086     DOI： 10.1007/s00125-008-1120-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Type 1 diabetes-related antibodies in the fetal circulation: prevalence and influence on cord insulin and birth weight in offspring of mothers with type 1 diabetes.

Authors:  R S Lindsay; A-G Ziegler; B A Hamilton; A A Calder; F D Johnstone; J D Walker
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

2.  Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia.

Authors:  R K Menon; R M Cohen; M A Sperling; W S Cutfield; F Mimouni; J C Khoury
Journal:  N Engl J Med       Date:  1990-08-02       Impact factor: 91.245

3.  Decrease of thyroid antibodies during pregnancy.

Authors:  M D'Armiento; H Salabé; G Vetrano; M Scucchia; A Pachi
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

4.  Metabolic and immunologic effects of insulin lispro in gestational diabetes.

Authors:  L Jovanovic; S Ilic; D J Pettitt; K Hugo; M Gutierrez; R R Bowsher; E J Bastyr
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes.

Authors:  Anders Lindholm; Lisbeth B Jensen; Philip D Home; Philip Raskin; Bernhard O Boehm; Jacob Råstam
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

6.  A new insulin immunoassay specific for the rapid-acting insulin analog, insulin aspart, suitable for bioavailability, bioequivalence, and pharmacokinetic studies.

Authors:  L Andersen; P N Jørgensen; L B Jensen; D Walsh
Journal:  Clin Biochem       Date:  2000-11       Impact factor: 3.281

7.  Cord blood insulin to assess the quality of treatment in diabetic pregnancies.

Authors:  P A Weiss; F Kainer; J Haas
Journal:  Early Hum Dev       Date:  1998-07-10       Impact factor: 2.079

8.  Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.

Authors:  Elisabeth R Mathiesen; Brendan Kinsley; Stephanie A Amiel; Simon Heller; David McCance; Santiago Duran; Shannon Bellaire; Anne Raben
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

9.  Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.

Authors:  Moshe Hod; Peter Damm; Risto Kaaja; Gerard H A Visser; Fidelma Dunne; Irina Demidova; Anne-Sofie Pade Hansen; Henriette Mersebach
Journal:  Am J Obstet Gynecol       Date:  2007-10-01       Impact factor: 8.661

10.  Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus.

Authors:  D J Pettitt; P Ospina; C Howard; H Zisser; L Jovanovic
Journal:  Diabet Med       Date:  2007-10       Impact factor: 4.359
  10 in total
  9 in total

Review 1.  Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.

Authors:  Celeste P Durnwald; Mark B Landon
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 2.  Glucose Targets and Insulin Choice in Pregnancy: What Has Changed in the Last Decade?

Authors:  Siobhán Bacon; Denice S Feig
Journal:  Curr Diab Rep       Date:  2018-08-16       Impact factor: 4.810

Review 3.  Insulin pumps in pregnancy: using technology to achieve normoglycemia in women with diabetes.

Authors:  Kristin Castorino; Rashid Paband; Howard Zisser; Lois Jovanovič
Journal:  Curr Diab Rep       Date:  2012-02       Impact factor: 4.810

Review 4.  Pharmacological Management of Gestational Diabetes Mellitus.

Authors:  Riki Bergel; Eran Hadar; Yoel Toledano; Moshe Hod
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 5.  Oral hypoglycemic agents: do the ends justify the means?

Authors:  Oded Langer
Journal:  Matern Health Neonatol Perinatol       Date:  2015-08-05

Review 6.  Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.

Authors:  Kirsten Nørgaard; Nithya Sukumar; Snorri B Rafnsson; Ponnusamy Saravanan
Journal:  Diabetes Ther       Date:  2018-04-05       Impact factor: 2.945

7.  Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.

Authors:  Simon Heller; Peter Damm; Henriette Mersebach; Trine Vang Skjøth; Risto Kaaja; Moshe Hod; Santiago Durán-García; David McCance; Elisabeth R Mathiesen
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 17.152

Review 8.  Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus.

Authors:  Rajeev Chawla; Jagat Jyoti Mukherjee; Manoj Chawla; Alok Kanungo; Meenakshi Sundaram Shunmugavelu; Ashok Kumar Das
Journal:  Med Sci (Basel)       Date:  2021-05-28

Review 9.  Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.

Authors:  Kjeld Hermansen; Mette Bohl; Anne Grethe Schioldan
Journal:  Drugs       Date:  2016-01       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.